JMPWA
TNDM icon

JP Morgan Private Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,545
Closed -$1.1M – 1983
2022
Q2 		$1.1M Sell
18,545
-25,001
-57% -$2.05M ﹤0.01% 1098
2022
Q1 		$5.06M Buy
43,546
+527
+1% +$61.5K 0.01% 608
2021
Q4 		$6.47M Sell
43,019
-2,289
-5% -$309K 0.01% 548
2021
Q3 		$5.41M Sell
45,308
-4,443
-9% -$490K 0.01% 575
2021
Q2 		$4.85M Buy
49,751
+9,511
+24% +$848K 0.01% 604
2021
Q1 		$3.55M Buy
40,240
+34
+0.1% +$3.16K 0.01% 592
2020
Q4 		$3.85M Buy
40,206
+14,330
+55% +$1.48M 0.01% 554
2020
Q3 		$2.94M Buy
25,876
+387
+2% +$40.7K 0.01% 549
2020
Q2 		$2.52M Buy
25,489
+7,607
+43% +$607K 0.01% 522
2020
Q1 		$1.15M Buy
17,882
+4,966
+38% +$348K 0.01% 666
2019
Q4 		$770K Hold
12,916
– – ﹤0.01% 892
2019
Q3 		$762K Sell
12,916
-1
-0% -$64 ﹤0.01% 854
2019
Q2 		$833K Hold
12,917
– – ﹤0.01% 804
2019
Q1 		$820K Buy
12,917
+3,400
+36% +$179K ﹤0.01% 859
2018
Q4 		$361K Buy
9,517
+297
+3% +$10.5K ﹤0.01% 1082
2018
Q3 		$395K Buy
+9,220
New +$322K ﹤0.01% 1173
2017
Q3 		– Sell
-5,884
Closed -$47K – 1278
2017
Q2 		$47K Hold
5,884
– – ﹤0.01% 1210
2017
Q1 		$71K Hold
5,884
– – ﹤0.01% 1299
2016
Q4 		$126K Buy
5,884
+3,964
+206% +$153K ﹤0.01% 1199
2016
Q3 		$147K Sell
1,920
-3,964
-67% -$289K ﹤0.01% 1172
2016
Q2 		$444K Buy
5,884
+3,964
+206% +$319K ﹤0.01% 820
2016
Q1 		$167K Hold
1,920
– – ﹤0.01% 1110
2015
Q4 		$227K Hold
1,920
– – ﹤0.01% 980
2015
Q3 		$169K Hold
1,920
– – ﹤0.01% 952
2015
Q2 		$208K Hold
1,920
– – ﹤0.01% 961
2015
Q1 		$242K Sell
1,920
-580
-23% -$75.4K ﹤0.01% 967
2014
Q4 		$318K Hold
2,500
– – ﹤0.01% 852
2014
Q3 		$336K Sell
2,500
-1,572
-39% -$220K ﹤0.01% 811
2014
Q2 		$662K Buy
+4,072
New +$693K 0.01% 496

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Private Wealth Advisors's TNDM Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 18,545 shares — an estimated $1.1M sold.

JP Morgan Private Wealth Advisors first reported a position in TNDM in Q2 2014 and held it in 29 quarters. The position peaked at $6.47M in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 18,545 Tandem Diabetes Care shares in Q3 2022, an estimated $1.1M.
  • JP Morgan Private Wealth Advisors first reported a position in Tandem Diabetes Care in Q2 2014 and held it in 29 quarters.
  • JP Morgan Private Wealth Advisors's Tandem Diabetes Care position peaked at $6.47M in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.